Cafepharma Today

February 6 2025 - Bristol Myers Squibb tops Q4 estimates
Bristol Myers Squibb tops Q4 estimates
AstraZeneca bounds higher on Q4 beat, upbeat guidance
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Pfizer taps a former Novartis exec to lead cancer drug push
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Biotech M&A Action: We've Only Just Begun
Seeking Alpha
Wednesday, March 25, 2009 - 8:24am
tags:
biotech, Amgen, Biogen Idec, Genzyme, Gilead Sciences, Merck, Pfizer
Dendreon Disclosure May Endanger Provenge Study
Forbes
Wednesday, March 25, 2009 - 8:22am
tags:
Dendreon, drug trials, prostate cancer, Provenge
Short Interest Rises in Merck and Johnson & Johnson
Seeking Alpha
Wednesday, March 25, 2009 - 8:20am
tags:
Merck, Schering Plough, JNJ
Arena's Financing Deal with Azimuth Is a Healthy Move
Seeking Alpha
Wednesday, March 25, 2009 - 7:44am
tags:
Arena Pharmaceuticals, obesity, Azimuth
Allergan Seeks Own Deals Amid Buyout Talk
TheStreet.com
Wednesday, March 25, 2009 - 7:43am
tags:
Allergan, buyouts, GSK
GSK promises full drug trial disclosure
FT.com
Wednesday, March 25, 2009 - 7:42am
tags:
GSK, drug trials
Wyeth gets expanded FDA approval for antibiotic to treat type of bacterial pneumonia
Yahoo/AP
Wednesday, March 25, 2009 - 7:41am
tags:
Wyeth, FDA, pneumonia, Tygacil
Swiss drugmaker Novartis offers to raise stake in Indian subsidiary to 90 percent
Yahoo/AP
Wednesday, March 25, 2009 - 7:40am
tags:
Novartis, India
Moody's lowers Sanofi-Aventis outlook to stable
Yahoo/AP
Tuesday, March 24, 2009 - 6:47pm
tags:
Sanofi
Taking the F Out of FDA
Motley Fool
Tuesday, March 24, 2009 - 6:46pm
tags:
FDA, Obama
Allergan soars on Glaxo takeover speculation
Marketwatch
Tuesday, March 24, 2009 - 6:30pm
tags:
Allergan, GSK, buyouts
SkyePharma files for Flutiform approval
Fierce Biotech
Tuesday, March 24, 2009 - 9:43am
tags:
Flutiform, SkyePharma, NDA, FDA, asthma
Amylin Shares Find Support, But Upside Still Limited
Seeking Alpha
Tuesday, March 24, 2009 - 9:41am
tags:
Amylin, Eli Lilly, Byetta
NeurogesX Fundamentals Improve
Seeking Alpha
Tuesday, March 24, 2009 - 9:14am
tags:
NeurogesX, Qutenza, neuropathic pain
GSK: Healthcare Is Not Always Defensive
Seeking Alpha
Tuesday, March 24, 2009 - 9:03am
tags:
GSK, JNJ, Sanofi, Pfizer, pipelines
Cubist suing Teva in patent dispute
Yahoo/AP
Tuesday, March 24, 2009 - 8:55am
tags:
Cubist Pharmaceuticals, Teva Pharmaceuticals, patents
Fighting Like a Wolfe Against Johnson & Johnson
InVivo
Tuesday, March 24, 2009 - 7:57am
tags:
JNJ, rivaroxaban
Hospira to cut workforce by about 10%
Marketwatch
Tuesday, March 24, 2009 - 7:55am
tags:
Hospira, layoffs
Merck Updates On $7 Billion In Financing For Schering Buyout
CNN Money
Tuesday, March 24, 2009 - 7:31am
tags:
Merck, Schering Plough, buyouts
Roche: safety concerns threaten future blockbuster
Pharmaceutical Business Review
Tuesday, March 24, 2009 - 7:28am
tags:
Roche, Actemra, rheumatoid arthritis

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information